Showing 2551-2560 of 8080 results for "".
Physician Spotlight: Murad Alam, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-murad-alam-md/23172/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-7/23139/Women in Dermatology: Melissa Kanchanapoomi Levin, MD
https://practicaldermatology.com/topics/practice-management/women-in-dermatology-melissa-kanchanapoomi-levin-md/23063/The State of Pediatric Dermatology
https://practicaldermatology.com/topics/practice-management/the-state-of-pediatric-dermatology/23060/The subspecialty needs to expand its workforce to continue to meet critical patient need.Prospective Analysis: PRP Post-Mohs; Physician Debt Insights
https://practicaldermatology.com/youngmd-connect/resident-resource-center/propsective-analysis-prp-post-mohs-physician-debt-insights/23038/The Showdown: Smartphone vs. DSLR Cameras
https://practicaldermatology.com/topics/practice-management/the-showdown-smartphone-vs-dslr-cameras/23031/Consistently capturing great photos can have a huge impact on your practice. Here’s what to consider.New in My Practice Rx: Seysara (sarecycline)
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-rx-seysara-sarecycline/20810/Approval for Evolus; Remembering Vic Narurkar, MD
https://practicaldermatology.com/topics/practice-management/dermwiretv-approval-for-evolus-remembering-vic-narurkar-md/19553/The FDA has approved Jeuveau, the lead product from Evolus, Inc. David Moatazedi, President and CEO of Evolus, and Michael Jafar, Chief Marketing Officer at Evolus, comment on market potential for the new product.Twenty-eight percent of physicians say the prior authorization process required by healHZ Masquerading as Periorbital Cellulitis Following Mohs Surgery; AMA Focuses on Physician Well-being, Suicide Prevention
https://practicaldermatology.com/youngmd-connect/resident-resource-center/hz-masquerading-as-periorbital-cellulitis-following-mohs-surgery-ama-focuses-on-physician-well-being-suicide-prevention/20374/Valeant's Siliq Cleared, AmSpa Survey, New Skin Cancer Imaging
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-valeant-s-siliq-cleared-amspa-survey-new-skin-cancer-imaging/18527/The FDA has approved Valeant Pharmaceutical's Siliq (brodalumab) injection for subcutaneous use for patients with moderate-to-severe plaque psoriasis. The American Med Spa Association (AmSpa) has extended the deadline for its comprehensive survey of MedSpas nationwide. Multiphoton microscopy of mito